 Jun.17 -- 23andMe Inc. CEO Anne Wojcicki discusses the DNA-testing companys NASDAQ trading debut, a collaboration on drug development with GlaxoSmithKline Plc, and the choice to go public through a merger with VG Acquisition Corp., a special-purpose acquisition company founded by billionaire Richard Branson. She speaks with Bloombergs Emily Chang on Bloomberg Markets: The Close. 